TY - JOUR
KW - Analgesics, Opioid/administration & dosage/urine
KW - Buprenorphine/administration & dosage/urine
KW - Enzyme Assays/methods
KW - Humans
KW - intravenous drug abuse
KW - Lactose/urine
KW - Limit of Detection
KW - Opiate Substitution Treatment
KW - opioid maintenance treatment
KW - Substance Abuse Detection/methods
KW - Substance Abuse, Intravenous/urine
KW - Sucrose/urine
KW - urine disaccharides
AU - T. Keltanen
AU - C. Mariottini
AU - A. M. Walta
AU - A. L. Rahikainen
AU - I. Ojanpera
A1 - 
BT - Drug testing and analysis
C5 - Opioids & Substance Use
CP - 6
CY - England
DO - 10.1002/dta.2050
IS - 6
JF - Drug testing and analysis
PB - John Wiley & Sons, Ltd
PP - England
PY - 2017
SN - 1942-7611; 1942-7603
SP - 949
EP - 952
EP - 
T1 - Enzymatic assays for detecting lactose and sucrose in urine to reveal intravenous drug abuse with emphasis on buprenorphine
T2 - Drug testing and analysis
TI - Enzymatic assays for detecting lactose and sucrose in urine to reveal intravenous drug abuse with emphasis on buprenorphine
U1 - Opioids & Substance Use
U2 - 27504930
U3 - 10.1002/dta.2050
VL - 9
VO - 1942-7611; 1942-7603
Y1 - 2017
ER -